Remote ischemic preconditioning for prevention of contrast-induced nephropathy – A randomized control trial()

BACKGROUND: There is a lack of sufficient data regarding the protective effects of remote ischemic preconditioning (RIPC) in patients at risk of developing contrast-induced nephropathy (CIN). Thus, this study was conducted to determine whether RIPC as an adjunct to standard therapy prevents CIN in h...

Descripción completa

Detalles Bibliográficos
Autores principales: Bafna, Akshay Ashok, Shah, Hetan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474124/
https://www.ncbi.nlm.nih.gov/pubmed/32861377
http://dx.doi.org/10.1016/j.ihj.2020.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474124/
https://www.ncbi.nlm.nih.gov/pubmed/32861377
http://dx.doi.org/10.1016/j.ihj.2020.04.010

Ejemplares similares